Related Articles for PubMed (Select 17640394)

Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.

Howe LR.

Breast Cancer Res. 2007;9(4):210. Review.

PMID: 17640394 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

The role of COX-2 inhibition in breast cancer treatment and prevention.

Arun B, Goss P.

Semin Oncol. 2004 Apr;31(2 Suppl 7):22-9. Review.

PMID: 15179621 [PubMed - indexed for MEDLINE]

Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.

Davies G, Martin LA, Sacks N, Dowsett M.

Ann Oncol. 2002 May;13(5):669-78. Review.

PMID: 12075734 [PubMed - indexed for MEDLINE]

Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.

Chell S, Kaidi A, Williams AC, Paraskeva C.

Biochim Biophys Acta. 2006 Aug;1766(1):104-19. Epub 2006 May 23. Review. Erratum in: Biochim Biophys Acta. 2007 Jun;1775(2):341. Kadi, Abderrahmane [corrected to Kaidi, Abderrahmane].

PMID: 16859832 [PubMed - indexed for MEDLINE]

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

Howe LR, Dannenberg AJ.

Semin Oncol. 2002 Jun;29(3 Suppl 11):111-9. Review.

PMID: 12138405 [PubMed - indexed for MEDLINE]

COX-2 inhibitors for the prevention of breast cancer.

Howe LR, Dannenberg AJ.

J Mammary Gland Biol Neoplasia. 2003 Jan;8(1):31-43. Review.

PMID: 14587862 [PubMed - indexed for MEDLINE]

Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy.

Sarkar FH, Adsule S, Li Y, Padhye S.

Mini Rev Med Chem. 2007 Jun;7(6):599-608. Review.

PMID: 17584158 [PubMed - indexed for MEDLINE]

Prognostic impact of cyclooxygenase-2 in breast cancer.

Denkert C, Winzer KJ, Hauptmann S.

Clin Breast Cancer. 2004 Feb;4(6):428-33. Review.

PMID: 15023244 [PubMed - indexed for MEDLINE]

The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.

Kong G, Kim HT, Wu K, DeNardo D, Hilsenbeck SG, Xu XC, Lamph WW, Bissonnette R, Dannenberg AJ, Brown PH.

Cancer Res. 2005 Apr 15;65(8):3462-9.

PMID: 15833882 [PubMed - indexed for MEDLINE]

10:

Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.

Sinicrope FA.

Mol Carcinog. 2006 Jun;45(6):447-54. Review.

PMID: 16688727 [PubMed - indexed for MEDLINE]

11:

Cyclooxygenase-2: a potential target in breast cancer.

Wang D, Dubois RN.

Semin Oncol. 2004 Feb;31(1 Suppl 3):64-73. Review.

PMID: 15052544 [PubMed - indexed for MEDLINE]

12:

Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer.

Díaz-Cruz ES, Brueggemeier RW.

Anticancer Agents Med Chem. 2006 May;6(3):221-32. Review.

PMID: 16712450 [PubMed - indexed for MEDLINE]

13:

Cyclooxygenases in hepatocellular carcinoma.

Cervello M, Montalto G.

World J Gastroenterol. 2006 Aug 28;12(32):5113-21. Review.

PMID: 16937518 [PubMed - indexed for MEDLINE]

14:

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.

Harris RE, Beebe-Donk J, Alshafie GA.

BMC Cancer. 2006 Jan 30;6:27.

PMID: 16445867 [PubMed - indexed for MEDLINE]

Recent Activity